DDIT3 and amyotrophic lateral sclerosis: In addition, inhibition of PERK signaling with IRSIB has been investigated in ALS rodent models, and a reduction in ATF4 and CHOP levels has been indicated (Figure 1, Table 2), which results in significant neuronal survival.